The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as ...

Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricingAdditional Novartis medicines will be made available through direct-to-patient platforms in 2026Company ...

Microsoft, Novartis and RTX headline Zacks' top research picks, spotlighting cloud, pharma innovation and defense demand ...

Dec 17 (Reuters) - ‌The ​White House ‌is set to announce ​drug pricing deals ‍with pharma giants ​Novartis AG ​and ⁠Roche ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...

Investing.com -- The White House is preparing to announce drug pricing agreements with Swiss pharmaceutical giants Novartis ...

Fintel reports that on December 11, 2025, GUGGENHEIM SECURITIES LLC maintained coverage of Novartis AG - Depositary Receipt ...

Have you been paying attention to shares of Novartis (NVS)? Shares have been on the move with the stock up 10.1% over the past month. The stock hit a new 52-week high of $105.76 in the previous ...

Novartis AG raised its profit forecast for a third time as investors look beyond this year for clues to the Swiss drugmaker’s future after the spinoff of its Sandoz generics business. Operating profit ...

New NATALEE 5-year sub-analysis data reinforce sustained reduction in distant disease-free survival in broadest population of EBC patients13 ...

Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion Avidity expects to separate its early-stage precision cardiology programs into a ...

Novartis AG (NYSE:NVS) on Thursday unveiled a sweeping $23 billion investment plan to expand its manufacturing and research infrastructure in the U.S. over the next five years. The move is part of a ...